Company
Ophiomics
- AI
- Biotech
- Location:
- Lisbon, Portugal
Description
Ophiomics develops diagnostic products combining artificial intelligence and genomics for precision liver medicine, helping clinicians assess liver disease for detection, outlook, therapy choice, and follow-up management.
Related
CAREPOI®CAREPOI® creates cloud-native AI healthcare intelligence and telemedicine platforms that link patients, clinicians, diagnostics, and…
OrganOxOrganOx builds and supplies the OrganOx metra liver perfusion device platform for normothermic machine perfusion, used by clinicians to…
Cyted HealthCyted Health combines minimally invasive cell collection with molecular analysis to build diagnostic tests (EndoSign®) for earlier…
Google DeepMindGoogle DeepMind researches and builds safe artificial intelligence systems, including Gemini Audio, Gemini Robotics 2, Co-Scientist, and…
Age LabsAge Labs develops biomarkers and predictive algorithms for early detection of age-related diseases, offering diagnostic tests, biological…
numares HEALTHnumares HEALTH develops biomarker tests that use nuclear magnetic resonance spectroscopy and machine learning to quantify serum metabolites…
deCODE geneticsdeCODE genetics operates a human gene-discovery engine that analyzes population-scale genomic data to identify genetic risk factors and…
- greenmetrics.aigreenmetrics.ai operates AI-driven, ultra-local flood detection systems that combine proprietary street-level sensors, dedicated radio…
EndoVia TherapeuticsEndoVia Therapeutics builds a precision oncology platform that combines tumor profiling and AI-driven digital twin models to predict,…